Nile Therapeutics Overview

  • Founded
  • 2005

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 19

Employees
  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 6

  • Investments
  • 2

Nile Therapeutics General Information

Description

Developer of products for cardiovascular and metabolic disease. The company develops product for the treatment of cardiovascular disease and other areas of unmet medical needs.

Contact Information

Formerly Known As
SMI Products
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • 8840 Wilshire Boulevard
  • 2nd Floor
  • Beverly Hills, CA 90211
  • United States
+1 (310) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nile Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nile Therapeutics‘s full profile, request access.

Request a free trial

Nile Therapeutics Patents

Nile Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160317622-A1 Methods of treatment of heart failure with natriuretic peptides Abandoned 29-Oct-2010 000000000
US-9314507-B2 Methods of treatment of heart failure with natriuretic peptides Expired - Fee Related 29-Oct-2010 000000000 0
US-20120178689-A1 Methods of treatment with natriuretic peptides Granted 29-Oct-2010 000000000 0
EP-2632477-A2 Methods of treatment with natriuretic peptides Withdrawn 29-Oct-2010 A61K38/22

Nile Therapeutics Executive Team (15)

Name Title Board Seat Contact Info
Louis Grasmick Director
Louis Manzo Director
Karen Krasney JD Executive Vice President & General Counsel
Thomas Copmann Ph.D Vice President, Regulatory Affairs and Drug Development
Rachel Smith Ph.D Vice President, Research & Development
You’re viewing 5 of 15 executive team members. Get the full list »

Nile Therapeutics Board Members (7)

Name Representing Role Since
0000 0000000000 00 Self Board Member 000 0000
00000 000000 Self Board Member 000 0000
00000 0000000 00 Self Executive Chairman 000 0000
You’re viewing 3 of 7 board members. Get the full list »

Nile Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nile Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nile Therapeutics‘s full profile, request access.

Request a free trial

Nile Therapeutics Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 (00 14-Oct-2014 0000000000 Hospitals/Inpatient Services
Capricor Therapeutics 21-Nov-2013 Reverse Merger Biotechnology 0000000 0
To view Nile Therapeutics’s complete acquisitions history, request access »